National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

velafermin
A recombinant human fibroblast growth factor-20 (rhFGF-20) protein with pro-proliferative activity. Velafermin stimulates DNA synthesis and cell proliferation, specifically promoting epithelial and mesenchymal cell proliferation, and may prevent radiation or chemotherapy-induced oral mucositis. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:recombinant human fibroblast growth factor-20
rhFGF-20
Code name:CG53135-05



Previous:vector-peptide conjugated paclitaxel, Vectrin, VEGFR-2 inhibitor peptide CT-322, VEGFR1-1084 peptide vaccine, VEGFR2-169 peptide vaccine
Next:Velban, VELCADE, Velsar, venlafaxine, Venofer

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov